Tumor types in this population of breast cancer patients included 25 (63%) triple negative, 12 (30%) hormone receptor positive (ER or PR ≥1%), and three (7%) HER2 overexpressed (see Table 1). The gene discussed is NR4A1; the disease is breast carcinoma.